Warning! GuruFocus detected
1 Severe warning sign
with METX.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
ME Therapeutics Holding Inc
NAICS : 541714
SIC : 3741
ISIN : CA5527671054
Description
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 12.06 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.08 | |||||
| Debt-to-EBITDA | -0.09 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 68.65 | |||||
| 9-Day RSI | 69.2 | |||||
| 14-Day RSI | 69.11 | |||||
| 3-1 Month Momentum % | 150 | |||||
| 6-1 Month Momentum % | 87.5 | |||||
| 12-1 Month Momentum % | 113.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.16 | |||||
| Quick Ratio | 8.16 | |||||
| Cash Ratio | 7.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.02 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -101.25 | |||||
| ROA % | -94.78 | |||||
| ROIC % | -2104.49 | |||||
| ROC (Joel Greenblatt) % | -2697.84 | |||||
| ROCE % | -100.16 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 198.12 | |||||
| Price-to-Tangible-Book | 210 | |||||
| EV-to-EBIT | -247.58 | |||||
| EV-to-EBITDA | -249.78 | |||||
| EV-to-FCF | -482.8 | |||||
| Price-to-Net-Current-Asset-Value | 210 | |||||
| Price-to-Net-Cash | 262.5 | |||||
| Earnings Yield (Greenblatt) % | -0.4 | |||||
| FCF Yield % | -0.18 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ME Therapeutics Holding Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -0.05 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 133.46 | ||
| 14-Day RSI | 69.11 | ||
| 14-Day ATR (C$) | 0.349525 | ||
| 20-Day SMA (C$) | 9.346 | ||
| 12-1 Month Momentum % | 113.68 | ||
| 52-Week Range (C$) | 0.75 - 11 | ||
| Shares Outstanding (Mil) | 29.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ME Therapeutics Holding Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ME Therapeutics Holding Inc Stock Events
| Event | Date | Price (C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
ME Therapeutics Holding Inc Frequently Asked Questions
What is ME Therapeutics Holding Inc(XCNQ:METX)'s stock price today?
The current price of XCNQ:METX is C$10.50. The 52 week high of XCNQ:METX is C$11.00 and 52 week low is C$0.75.
When is next earnings date of ME Therapeutics Holding Inc(XCNQ:METX)?
The next earnings date of ME Therapeutics Holding Inc(XCNQ:METX) is .
Does ME Therapeutics Holding Inc(XCNQ:METX) pay dividends? If so, how much?
ME Therapeutics Holding Inc(XCNQ:METX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers